子類別 期刊論文 [29/29] 會議論文/會議摘要 [10/15] 鄰近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群統計 近3年內發表的文件:7(15.91%) 含全文筆數:39(88.64%) 文件下載次數統計 下載大於0次:39(100.00%) 下載大於100次:37(94.87%) 檔案下載總次數:21324(0.40%) 最後更新時間: 2024-12-01 00:31 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Photothermal temperature-modulated ... Krüppel-like factor 10 as a prognos... Impact of pathological nodal stagin... Selection of patients with pancreat... Kruppel-like factor 10 modulates st... Carbohydrate antigen 19-9 response ... A phase II randomised trial of indu... Upregulating sirtuin 6 ameliorates ... Krupple like factor 10 modulates st... High expression of krüppel-like fac...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-44 / 44. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2024-08	Photothermal temperature-modulated cancer metastasis harnessed using proteinase-triggered assembly of near-infrared II photoacoustic/photothermal nanotheranostics	ACS Applied Materials and Interfaces. 2024 Aug 7;16(31):40611-40627.
2023-10-23	Krüppel-like factor 10 as a prognostic and predictive biomarker of radiotherapy in pancreatic adenocarcinoma	Cancers. 2023 Oct 23;15(21):Article number 5212.
2023-10	Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer	Lung Cancer. 2023 Oct;184:Article number 107357.
2023-09	Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized study	International Journal of Radiation Oncology Biology Physics. 2023 Sep 1;117(1):74-86.
2023-08-18	Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy	Radiation Oncology. 2023 Aug 18;18:Article number 137.
2023-06-12	Kruppel-like factor 10 modulates stem cell phenotypes of pancreatic adenocarcinoma by transcriptionally regulating notch receptors	Journal of Biomedical Science. 2023 Jun 12;30:Article number 39.
2022-04	A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study	British Journal of Cancer. 2022 Apr;126(7):1018-1026.
2021-10-26	Upregulating sirtuin 6 ameliorates glycolysis, EMT and distant metastasis of pancreatic adenocarcinoma with krüppel-like factor 10 deficiency	Experimental and Molecular Medicine. 2021 Oct 26;53:1623-1635.
2021-07	Krupple like factor 10 modulates stem cell phenotype of pancreatic adenocarcinoma via transcriptional regulation of Notch signal pathway	Cancer Research. 2021 Jul;81(13, Suppl.):Abstract number 2001.
2021-05	High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial	Radiotherapy and Oncology. 2021 May;158:146-154.
2018-10	Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study	Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 626PD.
2018-07	Therapeutic effect of repurposed temsirolimus in lung adenocarcinoma model	Frontiers in Pharmacology. 2018;9:Article number 778
2018-04	The role of consolidation chemoradiotherapy in Locally Advanced Pancreatic Cancer receiving chemotherapy: An updated systematic review and meta-analysis	Cancer Research and Treatment. 2018 Apr;50(2):562-574.
2018-03	Cure of unresectable, locally advanced pancreatic cancer after multidisciplinary therapy	Journal of Cancer Research and Practice. 2018 Mar;5(1):27-31.
2018-01	Tumor-macrophage fusion hybrids contribute to radiation-induced progression of pancreatic cancer	Molecular Cancer Therapeutics. 2018 Jan;17(1, Suppl.):A209.
2017-05	Second malignant neoplasms in a nationwide population-based cohort of childhood cancer survivors in Taiwan	Journal of Clinical Oncology. 2017 May;35:Meeting Abstract 10569.
2017-04-18	Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype	PLoS ONE. 2017 Apr 18;12(4):Article number e0175586.
2016-08-24	A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment	Journal of Biomedical Science. 2016 Aug 24;23:Article number 64.
2016-05	Bone marrow derived macrophages fuse with intestine stromal cells and contribute to chronic fibrosis after radiation	Radiotherapy and Oncology. 2016 May;119(2):250-258.
2015-08-08	Optimal combination of antiangiogenic therapy for hepatocellular carcinoma	World Journal of Hepatology. 2015 Aug 8;7(16):2029-2040.
2015-04	Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide	Hepatology International. 2015 Apr;9(2):258-268.
2015-02	Circulating cells contribute to cardiomyocyte regeneration after injury	Circulation Research. 2015 Feb;116(4):633-641.
2014-10	Depleting macrophage or blocking cell fusion machinery ameliorates intestine fibrosis after radiation	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3959.
2014-09	Radiation sensitization of tumor cells induced by shear stress: The roles of integrins and FAK	Biochimica et Biophysica Acta-Molecular Cell Research. 2014 Sep;1843(9):2129-2137.
2013-12	Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association	Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2013 Dec;1833(12):3035-3045.
2013-09	Strategies targeting fusion machinery of bone marrow derived macrophage may ameliorate intestinal fibrosis after radiation	European Journal of Cancer. 2013 Sep;49(Suppl. 2):S103.
2012-12	Bone marrow transplantation rescues intestinal mucosa after whole body radiation via paracrine mechanisms	Radiotherapy and Oncology. 2012 Dec;105(3):371-377.
2012-09	Bone marrow transplantation enhances trafficking of host-derived myelomonocytic cells that rescue intestinal mucosa after whole body radiation	Radiotherapy and Oncology. 2012 Sep;104(3):401-407.
2012-09	Bone marrow transplantation rescues intestinal mucosa after whole body radiation via paracrine mechanisms	Annals of Oncology. 2012 Sep;23(Suppl. 9):69.
2012-08	Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma	American Journal of Pathology. 2012 Aug;181(2):423-430.
2012-03	Fusion between bone marrow and intestine stromal cells contributes to intestine fibrosis after radiation	Radiotherapy and Oncology. 2012 Mar;102(Suppl. 1):S66-S67.
2012-02	Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma	International Journal of Radiation Oncology, Biology, Physics. 2012 Feb;82(2):817-825.
2011-12	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	International Journal of Radiation Oncology, Biology, Physics. 2011 Dec;81(5):e749-e757.
2011-09-24	Radiation sensitization of tumour cells induced by Shear Stress-Roles of Integrin Beta-1 and FAK	European Journal of Cancer. 2011 Sep 24;47:S143.
2011-04	Shear stress radiatio sensitizes colon cancer cells by downregulating FAK via integrin beta1	Cancer Research. 2011 Apr;71:Abstract number 569.
2010-10	Loss of Immunolabeling of kruppel like factor 10 is associated with advanced stage and rapid progression of pancreatic cancer	Annals of Oncology. 2010 Oct;21(Suppl. 8):73-74.
2009-11	Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer	Cancer Chemotherapy and Pharmacology. 2009 Nov;64(6):1173-1179.
2009-05-20	A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study	Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15562.
2009-05	Local radiotherapy suppresses granulocyte colony-stimulating factor induced tumor angiogenesis and metastasis	Cancer Research. 2009 May;69(9):Abstract number 711.
2007-05	Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result	Liver International. 2007 May;27(4):516-528.
2006-05	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	Journal of Gastroenterology and Hepatology. 2006 May;21(5):874-879.
2005-05	ATM regulates target switching to escalating doses of radiation in the intestines	Nature Medicine. 2005 May;11(5):484-490.
2004-10	Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of hepatocellular carcinoma	Radiotherapy and Oncology. 2004 Oct;73(Suppl. 1):S281.
2000-11	Differentiation induced by CDA-2 In xenografts is responsible for the antitumorigenesis of human hepatoma and renal cell carcinoma in SCID mice	Clinical Cancer Research. 2000 Nov;6:113.

顯示項目1-44 / 44. (共1頁) 1  每頁顯示[10|25|50]項目